SEROTONINERGIC MECHANISMS IN HYPERTENSION - FOCUS ON THE EFFECTS OF KETANSERIN

被引：116

作者：

VANHOUTTE, P

AMERY, A

BIRKENHAGER, W

BRECKENRIDGE, A

BUHLER, F

DISTLER, A

DORMANDY, J

DOYLE, A

FROHLICH, E

HANSSON, L

HEDNER, T

HOLLENBERG, N

JENSEN, HE

LUNDJOHANSEN, P

MEYER, P

OPIE, L

ROBERTSON, I

SAFAR, M

SCHALEKAMP, M

SYMOENS, J

TRAPJENSEN, J

ZANCHETTI, A

机构：

[1] CATHOLIC UNIV LEUVEN,LIEKENHUIS GASTHUISBERG,B-3000 LOUVAIN,BELGIUM

[2] UNIV LIVERPOOL,LIVERPOOL L69 3BX,ENGLAND

[3] FREE UNIV BERLIN,KLINIKUM STEGLITZ,D-1000 BERLIN 45,FED REP GER

[4] ST JAMES HOSP,LONDON SW12 8HW,ENGLAND

[5] UNIV MELBOURNE,DEPT PHYSIOL,PARKVILLE,VIC 3052,AUSTRALIA

[6] ALTON OCHSNER MED FDN & OCHSNER CLIN,NEW ORLEANS,LA 70121

[7] GOTHENBURG UNIV,DEPT CLIN PHARMACOL,S-41124 GOTHENBURG,SWEDEN

[8] BRIGHAM & WOMENS HOSP,BOSTON,MA 02115

[9] HVIDOVRE HOSP,DEPT DIALYSIS,DK-2650 HVIDOVRE,DENMARK

[10] HAUKELAND HOSP,DEPT INTERNAL MED,N-5016 BERGEN,NORWAY

[11] HOP NECKER ENFANTS MALAD,DEPT PHARMACOL,F-75730 PARIS 15,FRANCE

[12] UNIV CAPE TOWN,DEPT MED,CAPE TOWN,SOUTH AFRICA

[13] WESTERN INFIRM,BLOOD PRESSURE UNIT,GLASGOW G11 6NT,SCOTLAND

[14] HOP BROUSSAIS,F-75674 PARIS 14,FRANCE

[15] JANSSEN PHARMACEUT,DEPT CLIN RES,B-2340 BEERSE,BELGIUM

[16] FREDERIKSBERG HOSP,DEPT PHYSIOL,DK-2000 COPENHAGEN,DENMARK

[17] UNIV MILAN,CTR PHYSIOL CLIN & IPERTENS,IST CLIN MED GEN,I-20122 MILAN,ITALY

[18] ZUIDERZIEKENHUIS,DEPT INTERNAL MED,ROTTERDAM,NETHERLANDS

[19] UNIV KLIN BASEL,KANTONSSPITAL,BASEL,SWITZERLAND

[20] OSTRA HOSP,DEPT MED,GOTEBORG,SWEDEN

[21] AKAD ZIEKENHUIS DIJKZIGT,ROTTERDAM,NETHERLANDS

来源：

HYPERTENSION | 1988年 / 11卷 / 02期

关键词：

D O I：

10.1161/01.HYP.11.2.111

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：111 / 133

页数：23

共 325 条

[1]

ADT M, 1986, ANAESTESIOL INTENSIV, V17, P114

[2]

AHLMAN H, 1985, ANN SURG, V201, P81

[3] QT PROLONGATION AND TORSADE-DE-POINTES VENTRICULAR-TACHYCARDIA PRODUCED BY KETANSERIN [J].

ALDARIZ, AE ;

ROMERO, H ;

BARONI, M ;

BAGLIVO, H ;

ESPER, RJ .

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1986, 9 (06) :836-841

[4]

AMERY A, 1984, J CARDIOVASC PHARM, V6, P182

[5]

AMERY A, 1985, J CARDIOVASC PHARM, V7, pS176

[6] THE EFFECT OF KETANSERIN IN ESSENTIAL-HYPERTENSION [J].

ANDERSON, A ;

MORGAN, T ;

DUMPYS, R .

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1983, 10 (03) :331-333

[7]

ANDREN L, 1983, ACTA MED SCAND, V214, P125

[8]

ANGER C, 1985, BRIT J ANAESTH, V57, pP339

[9]

ANGER C, 1983, ANAESTHESIST S, V32, P323

[10]

ARNEKLONOBIN B, 1985, BLOOD VESSELS, V22, P1

← 1 2 3 4 5 6 7 8 9 10 →